Stem cell technology higher but not for new drug development.

Published: 2007-01-10 06:59:00

Updated: 2007-01-10 06:59:00

The level of embryo stem cell technology in Korea showed very high but not for the new drug development, indicating that in one way or others a certain supporting policy should be measured as early as possible.

The Korea Health Industry Development Institute (KHIDI) recently published a survey...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK